Moreover, AZD8186 is currently used in combination with docetaxel to treat patients with metastatic or unresectable PTEN- or PIK3CB-mutant advanced solid tumors, including breast cancers (NCT03218826). This evidence concerns the gene PIK3CB and breast carcinoma.